New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...

Oprah Winfrey discusses GLP-1 weight-loss medications and obesity as a disease, challenging long-held misconceptions about ...

By Dr. Sanchari Sinha Dutta, Ph.D. Analysis of a large unsubsidized digital weight-loss service reveals that consistent ...

Patients who discontinue popular weight-loss medications like Ozempic and Wegovy typically regain the weight they lost within ...

PEOPLE's new cover story features everyday people sharing their weight-loss success — with GLP-1s and without — and how they're staying healthy ...

Research has shown that people who stop taking GLP-1 drugs, such as Ozempic and Wegovy, typically experience weight regain ...

Jerry Clark says he's transformed his tastebuds, changed his portion sizes, and made fitness a non-negotiable.

User engagement in a digital weight-loss service enhanced the effectiveness of GLP-1 receptor agonists and the dual glucose-dependent insulinotropic polypeptide (GIP)-GLP-1 receptor agonists in adults ...

A new year can mean a new “you” as many Americans look to weight loss as a new years resolution. The team at CNOS in Dakota ...